Category
8 articles tagged Healthcare.
Protege co-founder NG Zidan explains why static benchmarks fail in clinical settings. The discussion highlights the critical need for independent, real-time AI evaluation to mitigate misalignment risks and establish market trust in high-stakes healthcare applications.
Analysis of Moderna's mRNA cancer vaccine success and its implications for the biotech sector. Expert insights on BioNTech's diversification, Novo Nordisk's competitive position, and the rising role of Chinese biotech innovation in global pharma.
Curative CEO Fred Turner details how custom AI agents replaced 80% of legacy SaaS spend, scaled provider contracting by 10x, and pivoted a $5B pandemic testing business into a $1.3B health insurer. Learn how orthogonal supply chains and AI-driven workflows are reshaping enterprise operations.
OpenAI leaders detail the strategic rollout of ChatGPT Health, focusing on safety-first model training, clinician trust, and the shift from reactive to proactive care. The analysis highlights how AI is reducing diagnostic errors and unlocking new drug discovery opportunities.
An analysis of the emerging market for AI care robots in aging populations. This brief examines the economic drivers, clinical outcomes, and ethical risks of deploying AI companions to address the loneliness epidemic in the US and South Korea.
An executive analysis of the emerging market for AI-driven mental health support. This brief examines the strategic opportunity to address the global therapy access gap, the operational risks of sycophancy in LLMs, and the necessity for specialized, clinically validated models to ensure user safety and commercial viability.
Chinese regulators urge banks to limit U.S. Treasury exposure, signaling geopolitical risk in global markets. Novo Nordisk shares surge as Hims & Hershey withdraws a copycat weight-loss pill following FDA crackdowns. Super Bowl 60 highlights defensive strategy and brand impact.
TrueMed founder Justin Maris discusses the structural causes of the US chronic disease crisis, the impact of crop subsidies on food quality, and the strategic opportunity to redirect tax-free HSA and FSA funds toward lifestyle interventions. The analysis covers regulatory gaps, the rise of peptides, and the shift from treatment to prevention in healthcare economics.
